THE Pulmonary Fibrosis Trust has welcomed the approval of nerandomilast (Jascayd) by the Medicines and Healthcare products Regulatory Agency (MHRA), describing it as an important milestone for thousands of people living with pulmonary fibrosis across the UK…
